|Brand name(s), other common name(s)||Folotyn®|
|How the drug is given||Intravenously (IV)|
Indications and Usage
Pralatrexate is FDA approved to treat people who have relapsed or refractory peripheral T-cell lymphoma. It is being studied to treat people who have other forms of lymphoma including diffuse large B-cell lymphoma.
Side effects needing medical attention
Mouth sores; tiredness (fatigue); nausea; myelosuppression; infections.
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.